Variant report
Variant | esv3345034 |
---|---|
Chromosome Location | chr13:86303401-86305524 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556490652 | chr13:86303406-86303407 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574887541 | chr13:86303424-86303425 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542499544 | chr13:86303430-86303431 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560806419 | chr13:86303551-86303552 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553860861 | chr13:86303572-86303573 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572673510 | chr13:86303616-86303617 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187367474 | chr13:86303627-86303628 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74102093 | chr13:86303673-86303674 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs138126140 | chr13:86303713-86303714 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550408321 | chr13:86303719-86303720 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562466704 | chr13:86303746-86303747 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529683688 | chr13:86303756-86303757 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543123407 | chr13:86303792-86303793 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561799797 | chr13:86303810-86303811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529013108 | chr13:86303929-86303930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566459967 | chr13:86303935-86303936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75614350 | chr13:86303942-86303943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374307330 | chr13:86304106-86304107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375738675 | chr13:86304107-86304108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114745769 | chr13:86304123-86304124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192198663 | chr13:86304131-86304132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538288881 | chr13:86304132-86304133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201998148 | chr13:86304136-86304137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149537682 | chr13:86304146-86304147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377003714 | chr13:86304155-86304156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369531696 | chr13:86304162-86304163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374225597 | chr13:86304170-86304171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375847177 | chr13:86304195-86304196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370215153 | chr13:86304216-86304217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371590128 | chr13:86304230-86304231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs372491973 | chr13:86304235-86304236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs527939538 | chr13:86304240-86304241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376994850 | chr13:86304243-86304244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111586147 | chr13:86304258-86304259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552911594 | chr13:86304265-86304266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370371138 | chr13:86304273-86304274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372786827 | chr13:86304284-86304285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571026444 | chr13:86304292-86304293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115213432 | chr13:86304294-86304295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376044911 | chr13:86304300-86304301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374805904 | chr13:86304303-86304304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370731084 | chr13:86304311-86304312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368871793 | chr13:86304330-86304331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535617374 | chr13:86304339-86304340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375342946 | chr13:86304346-86304347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375899813 | chr13:86304350-86304351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368130576 | chr13:86304351-86304352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554133522 | chr13:86304365-86304366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368539239 | chr13:86304366-86304367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371510118 | chr13:86304367-86304368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:86274000-86313200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr13:86303200-86304000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr13:86303400-86303800 | Flanking Active TSS | A549 | lung |
4 | chr13:86303400-86312600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr13:86303600-86303800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr13:86303800-86304000 | Enhancers | A549 | lung |
7 | chr13:86303800-86312600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |